Prevent insulin resistance from the comfort of your home. Our program was designed by medical leaders to treat metabolic dysfunction, the large silent pandemic affecting tens of millions of people.
Metformin is a well-known medication primarily used to manage type 2 diabetes, but it also has significant benefits for treating metabolic dysfunction. Metformin helps improve insulin sensitivity, reducing the amount of sugar your liver releases and your body absorbs. This process helps lower blood sugar levels and can lead to better metabolic function, decreasing the risk of various health issues. Metformin is typically taken in capsule form, providing a convenient and effective way to support your metabolic health. Your practitioner will tailor your dosage to fit your specific needs and health goals.
The risk of doing nothing
Patients with diabetes have greater risk of cardiovascular disease, as well as cancer and Alzheimer’s disease and other dementias.
If you are en route to metabolic dysfunction, you’re likely also en route to one or more of: cardiovascular disease, cancer, or Alzheimer’s disease.
The low-hanging fruit of longevity is proper metabolic function.
Obesity and metabolic dysfunction
Obesity is merely one symptom of an underlying metabolic derangement, such as hyperinsulinemia. Not everyone who is obese is metabolically unhealthy, and not everyone who is metabolically unhealthy is obese.
What is metabolism?
It's the process by which we take in nutrients and break them down for use in the body.
Better blood sugar control
Metformin helps regulate blood sugar levels, which can be particularly beneficial for those with type 2 diabetes or insulin resistance.
Heart health support
Promote cardiovascular health by reducing weight and improving lipid profiles.
Long-term results
Achieve and maintain your weight loss goals and metabolic health with the sustained effects of metformin.
It's the global epidemic of metabolic syndrome: insulin resistance, type 2 diabetes, NAFLD, and NASH. It's defined as having 3 or more of the following 5 criteria:
According to the National Institute of Diabetes and Digestive and Kidney Diseases (2021), the United States has 108 million obese people. Of these obese people, 67 million have metabolic syndrome. However, 33 million people have metabolic syndrome who are not obese. These 33 million people are at triple the risk of all-cause mortality and/or cardiovascular events than metabolically healthy normal-weight individuals.